DVAX Shares Outstanding History



Below is a table of the DVAX shares outstanding history going back to 11/10/2014:

Date DVAX Shares Outstanding
11/10/20140.03B
3/3/201528.91M
4/30/201529.30M
8/3/201538.40M
11/2/201538.43M
3/3/201638.48M
5/3/201638.50M
8/1/201638.50M
11/1/201638.53M
3/9/201744.35M
5/3/201748.79M
8/2/201754.75M
11/1/201760.60M
3/1/201861.68M
5/4/201862.27M
8/3/201862.62M
11/2/201862.69M
2/22/201964.00M
5/3/201965.07M
8/2/201965.15M
11/1/201983.87M
3/6/202086.19M
5/1/202092.18M
8/3/2020109.51M
11/2/2020110.17M
2/22/2021113.26M
5/3/2021114.59M
7/30/2021114.76M
11/1/2021119.95M
2/24/2022124.92M
5/2/2022126.31M
8/1/2022126.47M
11/1/2022127.58M
2/21/2023127.69M
8/1/2023128.80M
10/31/2023129.26M
2/20/2024130.61M
8/1/2024131.04M

Also see: DVAX Market Cap History
DVAX YTD Return
DVAX Historical Shares Outstanding:
+17.95% CAGR
DVAX Historical Shares Outstanding: +17.95% CAGR

Mouse over chart for data details
11/10/2014 ...8/1/2024
Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response. We show 38 historical shares outstanding datapoints in our coverage of DVAX's shares outstanding history.

Understanding the changing numbers of DVAX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DVAX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DVAX by allowing them to research DVAX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree DVAX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Dynavax Technologies (DVAX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

DVCR Shares Outstanding History
DXCM Shares Outstanding History
DYAI Shares Outstanding History
DYN Shares Outstanding History
DYNT Shares Outstanding History
EAR Shares Outstanding History
EBS Shares Outstanding History
ECOR Shares Outstanding History
ECYT Shares Outstanding History
EDAP Shares Outstanding History
More Healthcare companies »

 

DVAX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.